# The Veterinary Medicines (Amendment etc.) Regulations 2024, Regulation 162: Amendment to paragraph 1


In paragraph 1 (interpretation)—
(a) the existing text is renumbered as sub-paragraph (1);
(b) in sub-paragraph (1), in the definition of “pharmaceutical product”, at the end insert “or a biological veterinary medicinal product that is not immunological”;
(c) after that sub-paragraph insert—
“(2) For the purposes of this Schedule “manufacturing authorisation” means the following activities—
(a) manufacture or import of an authorised veterinary medicinal product;
(b) manufacture of a product to which paragraph 2 of Schedule 6 relates;
(c) manufacture of a product for administration under the cascade;
(d) manufacture of—
(i) an autogenous vaccine;
(ii) a stem cell product; or
(iii) a blood product for administration to non-food animals.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348258523/regulation/162 (the official version)
Page: https://openlegislation.uk/draft-veterinary-medicines-amendment-etc-regulations-2024/regulation-162
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.